CD8A and lung carcinoma: Getting a deeper knowledge of the evasion mechanisms that lung cancer induces in the cells of the immune system, and particularly in CD8+ T-cells, should lead to further understanding of lung cancer biology, downregulation of evasion mechanisms due to tumor cells and design of improved immunotherapeutic CD8+ T-cell-based regimes.